Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan.
Arch Toxicol. 2012 Sep;86(9):1453-64. doi: 10.1007/s00204-012-0829-z. Epub 2012 Mar 13.
Some renal carcinogens can induce karyomegaly, which reflects aberrant cell division in the renal tubules, from the early stages of exposure. To clarify the cell cycle-related changes during the early stages of renal carcinogenesis, we performed immunohistochemical analysis of tubular cells in male F344 rats treated with carcinogenic doses of representative renal carcinogens for 28 days. For this purpose, the karyomegaly-inducing carcinogens ochratoxin A (OTA), ferric nitrilotriacetic acid, and monuron, and the non-karyomegaly-inducing carcinogens tris(2-chloroethyl) phosphate and potassium bromate were examined. For comparison, a karyomegaly-inducing non-carcinogen, p-nitrobenzoic acid, and a non-carcinogenic non-karyomegaly-inducing renal toxicant, acetaminophen, were also examined. The outer stripe of the outer medulla (OSOM) and the cortex + OSOM were subjected to morphometric analysis of immunoreactive proximal tubular cells. Renal carcinogens, irrespective of their karyomegaly-inducing potential, increased proximal tubular cell proliferation accompanied by an increase in topoisomerase IIα-immunoreactive cells, suggesting a reflection of cell proliferation. Karyomegaly-inducing carcinogens increased nuclear Cdc2-, γH2AX-, and phosphorylated Chk2-immunoreactive cells in both areas, the former two acting in response to DNA damage and the latter one suggestive of sustained G₂. OTA, an OSOM-targeting carcinogen, could easily be distinguished from untreated controls and non-carcinogens by evaluation of molecules responding to DNA damage and G₂/M transition in the OSOM. Thus, all renal carcinogens examined facilitated proximal tubular proliferation by repeated short-term treatment. Among these, karyomegaly-inducing carcinogens may cause DNA damage and G₂ arrest in the target tubular cells.
一些肾致癌剂可诱导巨核细胞,反映出肾小管从早期暴露的异常细胞分裂。为了阐明肾致癌作用早期的细胞周期相关变化,我们用代表性肾致癌剂致癌剂量处理雄性 F344 大鼠 28 天后,对管状细胞进行免疫组织化学分析。为此,研究了诱导巨核细胞的致癌剂乌头酸 A(OTA)、三价铁氮三乙酸和灭草隆,以及非诱导巨核细胞的致癌剂三(2-氯乙基)磷酸酯和溴酸钾。为了比较,还研究了诱导巨核细胞的非致癌剂对硝基苯甲酸和非致癌非诱导巨核细胞的肾毒物对乙酰氨基酚。对皮质+外髓外带(OSOM)进行形态计量分析,检测免疫反应性近端肾小管细胞。无论是否具有诱导巨核细胞的能力,肾致癌剂均可增加近端肾小管细胞增殖,伴有拓扑异构酶 IIα 免疫反应性细胞增加,提示细胞增殖的反映。在两个区域,诱导巨核细胞的致癌剂增加了核 Cdc2、γH2AX 和磷酸化 Chk2 免疫反应性细胞,前两者对 DNA 损伤起作用,后者提示持续 G₂。OTA,一种靶向 OSOM 的致癌剂,通过评估 OSOM 中对 DNA 损伤和 G₂/M 转换有反应的分子,很容易与未处理的对照和非致癌剂区分开来。因此,所有研究的肾致癌剂都通过重复短期处理促进近端小管细胞增殖。其中,诱导巨核细胞的致癌剂可能在靶管状细胞中引起 DNA 损伤和 G₂ 停滞。